Partner Interview
Published August 19, 2025
Bio-Rad: Switching Costs and Competitive Dynamics in Single-Cell & Digital PCR
inpractise.com/articles/bio-rad-switching-costs-and-competitive-dynamics-in-single-cell-and-digital-pcr
Executive Bio
Former Director at Bio-Rad Laboratories
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
If you go to the core lab and say, "Hey, you've got a machine that produces this information, I'd like to offer you a cheaper machine that produces the same information," why is there a switching cost involved?
There are switching costs because, firstly, they need to prove that it's better. For example, Bio-Rad doesn't offer the same level of cell analysis; it does half the number of cells.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content
Bruker and AI Applications in Mass Spectrometry
Former Director of Bruker
Bruker: Products Overview
Former VP at Bruker
Medpace Holdings: Key Considerations in Selecting a CRO
Current VP of Clinical Operations at Biotech Company
Cytiva vs Sartorius: A Vaccine Customer's Perspective
Vaccine Manufacturing Lead at Sanofi
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.